NEW YORK ( TheStreet) -- Quidel Corporation (Nasdaq: QDEL) hit a new 52-week high Thursday as it is currently trading at $15.55, above its previous 52-week high of $15.53 with 54,252 shares traded as of 1:16 p.m. ET. Average volume has been 214,300 shares over the past 30 days. Quidel has a market cap of $501.5 million and is part of the health care sector and drugs industry. Shares are up 4.8% year to date as of the close of trading on Wednesday. Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of diagnostic testing solutions for applications primarily in infectious diseases, and reproductive and women's health. The company has a P/E ratio of 302.4, below the average drugs industry P/E ratio of 378 and above the S&P 500 P/E ratio of 17.7.
Practice your QDEL trading strategies and win cash in our stock game.
TheStreet Ratings rates Quidel as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Quidel Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.